On December 7, 2020, in a press release, the Council of the European Union (EU) announced that amendments are being adopted to allow member states, should they so wish, to temporarily exempt or apply a reduced rate of value added tax (VAT) to approved COVID-19 vaccines and testing kits. Members can also apply the exemption or lower rate of VAT to closely related services.
These measures will be applicable until December 31, 2022.
The press release can be found here: